Sinofn Health
Sinofn Health
In the current global industrial landscape, the paradigm of manufacturing has shifted from simple "production on demand" to "strategic collaborative innovation." The global supplement and health-food market is projected to reach unprecedented heights by 2030, driven by an aging population and a universal shift toward preventative wellness. For global enterprises, the selection of an OEM/ODM supplier is no longer just about cost-reduction; it is about risk mitigation, speed-to-market, and scientific validation.
As a leading OEM/ODM factory, SINOFN Health Co., Ltd. sits at the intersection of high-tech manufacturing and clinical research. Backed by the Chinese Academy of Sciences, we address the most critical pain points of modern procurement: supply chain transparency, regulatory compliance (ISO/HACCP/HALAL), and "Information Gain" in product formulation.
Enterprises are moving towards "China + 1" strategies, seeking factories that offer 4.0 automation and direct integration with global logistics. Reliability is the new currency.
Generic formulas are losing market share. Success now requires bioactive compound delivery systems and bioavailability optimization—areas where SINOFN excels.
With evolving EU and FDA regulations, our BRCGS-certified warehousing and blockchain batch tracking provide the safety net global brands require.
The "Made in China 2025" initiative has transformed factories like SINOFN into smart manufacturing hubs. By integrating AI-driven quality control and IoT-connected production lines, we reduce lead times by 35% compared to traditional manufacturers.
Founded in 2012, SINOFN was born out of a clinical need to provide affordable, science-backed PKU (Phenylketonuria) foods. Mrs. Liu’s vision attracted the Chinese Academy of Sciences to partner with us, bridging the gap between high-end medical nutrition and commercial availability.
"We measure success not just in revenue, but in lives improved through accessible science."
Our R&D team is led by doctoral candidates and associate researchers from the Chinese Academy of Sciences.
Ph.D Peking University Medical School
15+ years in metabolic disorder formulations
Associate Researcher, CAS Postdoc
Specialist in bioactive compound delivery systems
Senior Scientist (Netherlands)
EU regulatory specialist in nutraceutical delivery tech
10+ dedicated lines (softgels, gummies, powders). ISO 22000, HACCP, FSSC 22000 certified.
HPLC/GC-MS contaminant screening, microbiological safety testing, and stability validation.
Pilot-scale prototyping for tablets/capsules/liquids and bioavailability optimization studies.
Our OEM/ODM services are tailored for diverse global markets:
Unlike standard manufacturers, SINOFN is a high-tech enterprise backed by the Chinese Academy of Sciences. We provide "Information Gain" through proprietary R&D, clinical-grade testing, and specialized expertise in PKU and FSMP (Food for Special Medical Purposes).
We operate a dedicated pilot-scale R&D center that allows for small-batch runs (1000-5000 units) to validate formulations before moving to full-scale GMP production lines.
Our facilities are fully certified with ISO9001, ISO22000, HACCP, and HALAL. We also maintain BRCGS-certified warehousing to ensure safety during the international supply chain journey.
Yes. Our R&D Lead, Dr. Zhang Ying, and European Specialist Hans van Dijk help global brands adapt ingredients to comply with local FDA, EFSA, or Halal authority regulations.
Yes, our full-plant integration includes blockchain-ready systems that allow for end-to-end transparency from raw material sourcing to the consumer's hand.
